
Alora Medical RespiPEP Award marks a major milestone for the South African firm, which earned the Best Lung Clearing Device Brand 2026 title at the Global Health & Pharma Healthcare & Pharmaceutical Awards for its RespiPEP range. This achievement underscores the company’s role in expanding access to effective respiratory care across the region.
The Alora Medical RespiPEP Award highlights rising interest in non-invasive tools that support airway clearance and lung rehabilitation. Devices such as RespiPEP Therafizz and RespiPEP Theravance deliver Positive Expiratory Pressure therapy to improve lung volume, ease hyperinflation, and clear secretions in chronic respiratory conditions.
Regulatory Strength Behind the Devices
Alora Medical operates as a SAHPRA-licensed manufacturer, ensuring its RespiPEP products meet strict quality standards while remaining available through hospitals and clinics in South Africa and neighbouring countries. All devices require oversight by qualified healthcare professionals.
Market Opportunities for Affordable Lung Care
The recognition may open doors for wider adoption of cost-effective Positive Expiratory Pressure solutions, supporting preventive lung health and post-operative recovery programmes. It also strengthens the case for reimbursement frameworks that value accessible, clinically proven respiratory technologies.
Recent Posts

Lingjian Morphology Diagnostics Transforming Clinical Laboratory Practices

Mapping Vulnerable Elderly Care in the Netherlands
